alexa Anil Philip Kunnath
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Anil Philip Kunnath

Faculty of Medicine and Health Sciences, IMU, Malaysia
Biography

Anil Philip Kunnath is currently working as a researcher at Faculty of Medicine and Health Sciences, IMU, Malaysia. His research focuses on Cancer therapy, Targeted drug delivery systems, Nanomedicine, Nanotechnology, Cell biology, Bionanoscience and Nanomaterial. He has coauthored and published many research articles in various national and international scientific journals

Research Interest

His research focuses on Cancer therapy, Targeted drug delivery systems, Nanomedicine, Nanotechnology, Cell biology, Bionanoscience and Nanomaterial.

Publications

Intracellular Delivery of ERBB2 siRNA and p53 Gene Synergistically Inhibits the Growth of Established Tumor in an Immunocompetent Mouse

Anil Philip Kunnath, Snigdha Tiash, Tahereh Fatemian, Mahboob Morshed, Shar Mariam Mohamed and Ezharul Hoque Chowdhury

Research Article: J Cancer Sci Ther/Vol.6.4 099-104 (2014)

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords